Palomares Sara Morales, Cipolla Marilyn J
Departments of Neurology, Obstetrics, Gynecology & Reproductive Sciences and Pharmacology, University of Vermont, Burlington, Vermont.
J Neurol Neurophysiol. 2011 Sep 20;2011. doi: 10.4172/2155-9562.s1-004.
Despite considerable research that has contributed to a better understanding of the pathophysiology of stroke, translation of this knowledge into effective therapies has largely failed. The only effective treatment for ischemic stroke is rapid recanalization of an occluded vessel by dissolving the clot with tissue plasminogen activator (tPA). However, stroke adversely affects vascular function as well that can cause secondary brain injury and limit treatment that depends on a patent vasculature. In middle cerebral arteries (MCA), ischemia/reperfusion (I/R) cause loss of myogenic tone, vascular paralysis, and endothelial dysfunction that can lead to loss of autoregulation. In contrast, brain parenchymal arterioles retain considerable tone during I/R that likely contributes to expansion of the infarct into the penumbra. Microvascular dysregulation also occurs during ischemic stroke that causes edema and hemorrhage, exacerbating the primary insult. Ischemic injury of vasculature is progressive with longer duration of I/R. Early postischemic reperfusion has beneficial effects on stroke outcome but can impair vascular function and exacerbate ischemic injury after longer durations of I/R. This review focuses on current knowledge on the effects of I/R on the structure and function of different vascular segments in the brain and highlight some of the more promising targets for vascular protection.
尽管已有大量研究有助于更好地理解中风的病理生理学,但将这些知识转化为有效疗法在很大程度上却未成功。缺血性中风唯一有效的治疗方法是通过组织纤溶酶原激活剂(tPA)溶解血栓,使闭塞血管迅速再通。然而,中风也会对血管功能产生不利影响,进而导致继发性脑损伤,并限制依赖于血管通畅的治疗。在大脑中动脉(MCA)中,缺血/再灌注(I/R)会导致肌源性张力丧失、血管麻痹和内皮功能障碍,进而导致自动调节功能丧失。相比之下,脑实质小动脉在I/R期间保持相当的张力,这可能导致梗死灶向半暗带扩展。缺血性中风期间也会发生微血管调节异常,导致水肿和出血,加重原发性损伤。血管的缺血性损伤会随着I/R持续时间的延长而进展。缺血后早期再灌注对中风预后有有益影响,但在较长时间的I/R后会损害血管功能并加重缺血性损伤。本综述聚焦于I/R对脑内不同血管段结构和功能影响的现有知识,并突出一些更有前景的血管保护靶点。